Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell pathology in mood disorders.

Grazyna Rajkowska1

  • 1Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS 39216, USA.

Seminars in Clinical Neuropsychiatry
|October 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paranode length in the prefrontal cortex of subjects with major depression and rats under chronic unpredictable stress.

Journal of affective disorders·2025
Same author

Reduced length of nodes of Ranvier and altered proteoglycan immunoreactivity in prefrontal white matter in major depressive disorder and chronically stressed rats.

Scientific reports·2023
Same author

Layer III pyramidal cells in the prefrontal cortex reveal morphological changes in subjects with depression, schizophrenia, and suicide.

Translational psychiatry·2022
Same author

Cellular 3D-reconstruction and analysis in the human cerebral cortex using automatic serial sections.

Communications biology·2021
Same author

Transcriptome Analysis of Post-Mortem Brain Tissue Reveals Up-Regulation of the Complement Cascade in a Subgroup of Schizophrenia Patients.

Genes·2021
Same author

Exploring autoantibody signatures in brain tissue from patients with severe mental illness.

Translational psychiatry·2020
Same journal

Responses to cancer diagnosis and treatment: posttraumatic stress and posttraumatic growth.

Seminars in clinical neuropsychiatry·2003
Same journal

Mood disturbance in the cancer setting: effects of gender and patient/spouse role.

Seminars in clinical neuropsychiatry·2003
Same journal

The efficacy of behavioral interventions for cancer treatment-related side effects.

Seminars in clinical neuropsychiatry·2003
Same journal

Psychopharmacologic management during cancer treatment.

Seminars in clinical neuropsychiatry·2003
Same journal

Distinguishing fatigue and depression in patients with cancer.

Seminars in clinical neuropsychiatry·2003
Same journal

Delirium in the course of cancer treatment.

Seminars in clinical neuropsychiatry·2003
See all related articles

Neuroanatomic studies reveal significant reductions in glial cells and altered neurons in the brains of patients with mood disorders. These findings support cellular changes as a key factor in major depressive and bipolar disorders.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Psychiatry

Background:

  • Mood disorders, including major depressive disorder and bipolar disorder, are complex brain conditions.
  • Current understanding often focuses on neurochemical imbalances or functional connectivity.
  • Postmortem studies offer direct insights into cellular-level neuropathology.

Purpose of the Study:

  • To review quantitative cytomorphologic findings from postmortem studies of mood disorders.
  • To investigate glial and neuronal cell alterations in frontolimbic brain regions.
  • To explore the link between cellular changes and psychotherapeutic drug actions.

Main Methods:

  • Quantitative cytomorphologic analysis of postmortem brain tissues.
  • Microscopic examination of glial and neuronal cell counts and density.

Related Experiment Videos

  • Comparison of findings with neuroimaging and preclinical animal studies.

    • Main Results:

    • Marked reductions in glial cell number and density observed in patients with mood disorders.
    • Subtle alterations in cortical neuron density and size noted in frontolimbic regions.
    • Findings align with evidence of cell atrophy, loss, and impaired neuroplasticity.

    Conclusions:

    • Mood disorders are characterized by significant neuroanatomic changes at the cellular level.
    • Glial and neuronal alterations in frontolimbic areas are implicated in the pathophysiology.
    • Cellular changes may be a target for novel therapeutic interventions and understanding drug mechanisms.